291 related articles for article (PubMed ID: 18628430)
21. The effect of a 2-h exposure to cigarette smoke on the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Brown BG; Richter E; Tricker AR; Ayres PH; Doolittle DJ
Chem Biol Interact; 2001 Nov; 138(2):125-35. PubMed ID: 11672696
[TBL] [Abstract][Full Text] [Related]
22. Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.
Yuan JM; Stepanov I; Murphy SE; Wang R; Allen S; Jensen J; Strayer L; Adams-Haduch J; Upadhyaya P; Le C; Kurzer MS; Nelson HH; Yu MC; Hatsukami D; Hecht SS
Cancer Prev Res (Phila); 2016 May; 9(5):396-405. PubMed ID: 26951845
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism.
Hecht SS; Hatsukami DK; Bonilla LE; Hochalter JB
Chem Res Toxicol; 1999 Feb; 12(2):172-9. PubMed ID: 10027795
[TBL] [Abstract][Full Text] [Related]
24. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats.
Leslie EM; Ghibellini G; Nezasa K; Brouwer KL
Carcinogenesis; 2007 Dec; 28(12):2650-6. PubMed ID: 17724374
[TBL] [Abstract][Full Text] [Related]
27. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
[TBL] [Abstract][Full Text] [Related]
28. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
29. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
[TBL] [Abstract][Full Text] [Related]
30. Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat.
Schulze J; Richter E; Binder U; Zwickenpflug W
Carcinogenesis; 1992 Nov; 13(11):1961-5. PubMed ID: 1423863
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
32. The profile of urinary metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats is determined by its pulmonary metabolism.
Schneider T; Frei E; Wiessler M
Chem Biol Interact; 1999 Apr; 118(3):247-66. PubMed ID: 10362230
[TBL] [Abstract][Full Text] [Related]
33. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
Carmella SG; Ye M; Upadhyaya P; Hecht SS
Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
[TBL] [Abstract][Full Text] [Related]
34. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
[TBL] [Abstract][Full Text] [Related]
35. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
[TBL] [Abstract][Full Text] [Related]
36. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats.
Morse MA; Eklind KI; Toussaint M; Amin SG; Chung FL
Carcinogenesis; 1990 Oct; 11(10):1819-23. PubMed ID: 2208595
[TBL] [Abstract][Full Text] [Related]
38. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
39. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
40. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.
Park SL; Carmella SG; Ming X; Vielguth E; Stram DO; Le Marchand L; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):561-9. PubMed ID: 25542827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
